Carin Lamm, MD

I am privileged to have achieved my lifelong goal of becoming a pediatric gastroenterologist, more specifically a pediatric neurogastroenterologist. I have a special interest and expertise in disorders of the gut-brain interaction, including motility disorders, which involve the movement of food through the GI tract, and functional disorders, which involve interactions between the brain and GI tract that affect motility. These conditions can be debilitating and yet they remain challenging to treat effectively. My team and I evaluate and treat children and adolescents using advanced, state-of-the-art diagnostic and therapeutic techniques with multidisciplinary approach. Some of the conditions we treat are dysphagia, achalasia, gastroesophageal reflux disease, chronic nausea, gastroparesis, irritable bowel syndrome, chronic abdominal pain, severe constipation, fecal incontinence, and anorectal disorders. We think of our patients and their problems holistically and take pride in developing personal connections with patients and their families. My goal is to deliver compassionate, respectful, evidence-based, and humanistic care to children with gastrointestinal diseases. I co-direct many multidisciplinary clinics, including the Gastrointestinal Motility Center, Esophageal Atresia Clinic, Aerodigestive Program, and Congenital Diaphragmatic Hernia Program, and I work closely with pediatric surgeons, pulmonologists, cardiologists, ear nose throat (ENT) specialists, psychologists, and language pathologists to provide the most comprehensive care to children with complex GI medical conditions. I also take great pride in educating medical students, residents, fellows, and other providers. I have mentored several GI fellows who have joined other institutions across the county and are currently working to establish multidisciplinary clinics and expand access to care for functional and motility disorders. In addition to my clinical and education roles, my team and I conduct multiple clinical research projects focusing on functional and motility disorders. I work on clinical trials which allow our patients to have access to therapeutics that are not otherwise offered to children. This work has led to numerous presentations at national meetings and publications in high impact gastroenterology journals—all with the mission of improving children’s health and advancing the science of gastrointestinal motility and functional gastrointestinal diseases.

Elizabeth Anne Nofi Berg, MD is a renowned Gastroenterology specialist at CUIMC NewYork-Presbyterian Morgan Stanley Children's Hospital in New York, NY. With expertise in Pediatric Gastroenterology, Dr. Berg provides exceptional care and treatment for young patients in need of digestive health services. Generated from their website's infomation

Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms. Among the disorders he has described and/or found major mechanistic insight are PLAID—an immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. Dr. Milner graduated with an SB in biology from the Massachusetts Institute of Technology (MIT) in 1995 and an MD with distinction in immunology from the Albert Einstein College of Medicine. He completed his residency in pediatrics at the Children’s National Medical Center in Washington, DC, and, as the recipient of the Pediatric Scientist Development Program Fellowship, did his fellowship in allergy and immunology at NIAID. He completed a postdoctoral fellowship with Dr. William E. Paul, NIAID, examining issues of mouse T-cell receptor repertoires before beginning as an investigator in the Laboratory of Allergic Diseases in the NIAID, where he was eventually named chief. Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all patients with allergic disease—rare and common, severe and mild. This is achieved by performing genetic sequencing on samples from patients with allergic disease of all sorts, as well as performing functional studies on the same patient samples, which together help point to specific immune pathways that may be fundamentally causing disease. This comprehensive analysis, when performed in larger populations, will help personalize medicine so that patients can be better categorized for targeted care. Furthermore, this type of research and care requires a coordinated and comprehensive interdisciplinary approach, taking advantage of the expertise across the department of pediatrics and at multiple outpatient sites.